Treatment of Wilms Tumor: A Report from the Turkish Pediatric Oncology Group (TPOG)
✍ Scribed by Canan Akyüz; Bilgehan Yalçin; İnci Yildiz; Volkan Hazar; Asım YörÜk; Gülnur Tokuç; Ferhan Akici; Nebil Büyükpamukçu; Gülsev Kale; Lale Atahan; Cenk Büyükünal; Sergülen Dervişoğlu; Gülyüz Akyil Atkovar; Mustafa Melikoğlu; Gülten Karpuzoğlu; Nur Olgun; İnci Ayan; Aynur Oğuz; Nilgün Yarış; Ayhan Dağdemir; Emin Darendeliler; Serdar Sander; Uğur Kuyumcuoğlu; Naciye Özşeker; Funda Çorapçıoğlu; Atilla Tanyeli; Öznur Düzovalı; G. Burça Aydın; Münevver Büyükpamukçu
- Book ID
- 117983094
- Publisher
- Elsevier Science
- Year
- 2010
- Tongue
- English
- Weight
- 52 KB
- Volume
- 6
- Category
- Article
- ISSN
- 1477-5131
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
The purpose of this study was to evaluate the effect of the sequential addition of doxorubicin and cyclophosphamide to the combination of vincristine and actinomycin D o n the relapse-free survival of children with stage IV/favorable histology Wilms tumor. We reviewed the clinical courses of all ran
This report defines the incidence and determines the etiology of renal failure (RF) in patients undergoing treatment for Wilms' tumor (W). The database of the National Wilms' Tumor Study (NWS) was searched to identify all children reported to have developed chronic renal failure. There were 55 patie